Captain James A. Lovell Federal Health Care Center
North Chicago, Illinois, 60064, United States
Location contact
Bharathi Swaminathan, MD
CONTACT
James K Buskirk, PT, DPT, PhD, MS Ed
CONTACT
James K Buskirk, PT, DPT, PhD, MS Ed
SUB_INVESTIGATOR
NCT Number: NCT07094230
Use of blood biomarkers and eye tracking after traumatic brain injury for recovery timeline prediction
Trial opening soon.
Get Notified18 year–85 year
All sexes
Interventional
Not applicable
North Chicago, Illinois, 60064, United States
Bharathi Swaminathan, MD
CONTACT
James K Buskirk, PT, DPT, PhD, MS Ed
CONTACT
James K Buskirk, PT, DPT, PhD, MS Ed
SUB_INVESTIGATOR
Use of blood biomarkers and video IR oculography after mTBI for necessity of head CT scan and recovery timeline prediction
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients aged 18-85, Communicative in English language, With clinician-confirmed mTBI (GCS 13-15, ≤24 hours post-injury)
Exclusion criteria
Neurological, vestibular, or visual disorders, Significant comorbidities, Prior TBI (<6 months) Special populations (pregnant, incarcerated, active-duty recruits). Active-duty recruits excluded due to inability to contact them at scheduled intervals for remote follow-up questionnaires.
-
blood analyses
Time frame: same day
Alinity device analyses of GFAP and UCH-L1
Contact information is provided by the study sponsor or research team.
Captain James A. Lovell Federal Health Care Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05329493
Blood
Boston, Massachusetts, United States
View Trial DetailsNCT05974319
Blood, Fear
Ankara, Keçiören, Turkey (Türkiye)
View Trial DetailsNCT01547858
Blood, Chemical Industry
Guangzhour, China
View Trial DetailsNCT03242525
Analysis, Event History, Blood
Frankfurt am Main, Hesse, Germany
View Trial Details